<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T20:22:07Z</responseDate>
  <request identifier="oai:figshare.com:article/34046963" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34046963</identifier>
        <datestamp>2026-10-01T16:25:07Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_133</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancer</dc:title>
          <dc:creator>Di Xu (1443394)</dc:creator>
          <dc:creator>Xiaoyan Xu (283959)</dc:creator>
          <dc:creator>Fei Deng (170132)</dc:creator>
          <dc:creator>Liping Dong (255033)</dc:creator>
          <dc:creator>Wei Zhang (405)</dc:creator>
          <dc:creator>Yang Wu (66682)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Plant Biology</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>Breast cancer</dc:subject>
          <dc:subject>chemoresistance</dc:subject>
          <dc:subject>mesenchymal stem cells (MSCs)</dc:subject>
          <dc:subject>exosomes</dc:subject>
          <dc:subject>heat preconditioning</dc:subject>
          <dc:subject>tumor spheroids</dc:subject>
          <dc:description>&lt;p&gt;Objective: Drug resistance remains a major obstacle to chemotherapy in breast cancer. human bone marrow-derived mesenchymal stem cells (MSC)-derived exosomes are promising drug-delivery nanocarriers, but their anticancer efficacy is limited by insufficient cargo loading. We aimed to engineer MSC-derived exosomes with enhanced anti-resistance activity via mild heat preconditioning. Methods: MSCs were preconditioned at 41°C for 1 h (heat-preconditioned exosomes, HP-Exo) or at 37°C (non-heat-preconditioned exosomes, No HP-Exo). Exosome yield, stemness, and microRNA (miRNA) profiles were assessed. MCF-7/ADR doxorubicin (DOX)-resistant cells were cultured as three-dimensional (3D) spheroids and treated with HP-Exo or No HP-Exo with or without DOX; cell viability and apoptosis were evaluated. Results: Heat preconditioning preserved MSC stemness and increased exosome secretion via Rab27b upregulation. HP-Exo, but not No HP-Exo, sensitized MCF-7/ADR spheroids to DOX, enhancing apoptosis. HP-Exo delivered microRNA-486-5p (miR-486-5p), which directly targeted high mobility group AT-hook 1 (HMGA1), downregulating breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp). miR-486-5p inhibition abrogated, and its mimic restored, this chemosensitizing effect. Conclusion: Mild heat preconditioning is a simple strategy to engineer MSC-derived exosomes with enriched tumor-suppressive microRNA cargo and enhanced chemosensitizing activity, offering a promising nanotherapeutic platform to overcome chemoresistance in breast cancer.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T16:25:07Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34046963.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Heat-preconditioned_MSC-derived_exosomal_miR_486_5p_reverses_doxorubicin_resistance_in_breast_cancer/34046963</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
